Understanding Cystic Fibrosis Comorbidities and Their Impact on Nutritional Management

Overview

Journal Nutrients

Date 2022 Mar 10

PMID 35268004

Authors

Dhiren Patel

Albert Shan

Stacy Mathews

Meghana Sathe

Affiliations

Soon will be listed here.

Abstract

Cystic fibrosis (CF) is a chronic, multisystem disease with multiple comorbidities that can significantly affect nutrition and quality of life. Maintaining nutritional adequacy can be challenging in people with cystic fibrosis and has been directly associated with suboptimal clinical outcomes. Comorbidities of CF can result in significantly decreased nutritional intake and intestinal absorption, as well as increased metabolic demands. It is crucial to utilize a multidisciplinary team with expertise in CF to optimize growth and nutrition, where patients with CF and their loved ones are placed in the center of the care model. Additionally, with the advent of highly effective modulators (HEMs), CF providers have begun to identify previously unrecognized nutritional issues, such as obesity. Here, we will review and summarize commonly encountered comorbidities and their nutritional impact on this unique population.

Citing Articles

Challenges to Optimizing Nutrition in Children With Cystic Fibrosis.

Chen C, Granneman J, Yadav S Curr Gastroenterol Rep. 2025; 27(1):20.

PMID: 40053205 DOI: 10.1007/s11894-025-00969-5.

Using Community Engagement to Create a Telecoaching Intervention to Improve Self-Management in Adolescents and Young Adults With Cystic Fibrosis: Qualitative Study.

Duncan C, Muther E, Lindwall J, Durkin K, Ruvalcaba E, Williamson E J Particip Med. 2025; 17:e49941.

PMID: 39832355 PMC: 11791463. DOI: 10.2196/49941.

Collaboration between registered dietitians and gastroenterologists in cystic fibrosis care: Results of an international cross-sectional survey.

Sankararaman S, Schindler T, Leonard A, Vavrina K, Bailey J, Thavamani A Nutr Clin Pract. 2024; 40(1):195-208.

PMID: 39377560 PMC: 11713212. DOI: 10.1002/ncp.11219.

A Gastroenterologist's Guide to Care Transitions in Cystic Fibrosis from Pediatrics to Adult Care.

Patel D, Baliss M, Saikumar P, Numan L, Teckman J, Hachem C Int J Mol Sci. 2023; 24(21).

PMID: 37958749 PMC: 10648514. DOI: 10.3390/ijms242115766.

Evolving Nutritional Needs in Cystic Fibrosis.

Frantzen T, Barsky S, LaVecchia G, Marowitz M, Wang J Life (Basel). 2023; 13(7).

PMID: 37511806 PMC: 10381916. DOI: 10.3390/life13071431.

References

Furnari M, De Alessandri A, Cresta F, Haupt M, Bassi M, Calvi A . The role of small intestinal bacterial overgrowth in cystic fibrosis: a randomized case-controlled clinical trial with rifaximin. J Gastroenterol. 2018; 54(3):261-270. DOI: 10.1007/s00535-018-1509-4. View

Wytiaz V, Homko C, Duffy F, Schey R, Parkman H . Foods provoking and alleviating symptoms in gastroparesis: patient experiences. Dig Dis Sci. 2015; 60(4):1052-8. DOI: 10.1007/s10620-015-3651-7. View

Randlesome K, Bryon M, Evangeli M . Developing a measure of eating attitudes and behaviours in cystic fibrosis. J Cyst Fibros. 2012; 12(1):15-21. DOI: 10.1016/j.jcf.2012.05.005. View

Duggan C, Colin A, Agil A, Higgins L, Rifai N . Vitamin A status in acute exacerbations of cystic fibrosis. Am J Clin Nutr. 1996; 64(4):635-9. DOI: 10.1093/ajcn/64.4.635. View

Lindblad A, Glaumann H, Strandvik B . Natural history of liver disease in cystic fibrosis. Hepatology. 1999; 30(5):1151-8. DOI: 10.1002/hep.510300527. View

Valamparampil J, Gupte G . Cystic fibrosis associated liver disease in children. World J Hepatol. 2021; 13(11):1727-1742. PMC: 8637674. DOI: 10.4254/wjh.v13.i11.1727. View

Lu P, Moore-Clingenpeel M, Yacob D, Di Lorenzo C, Mousa H . The rising cost of hospital care for children with gastroparesis: 2004-2013. Neurogastroenterol Motil. 2016; 28(11):1698-1704. DOI: 10.1111/nmo.12869. View

Lavie M, Manovitz T, Vilozni D, Levy-Mendelovich S, Sarouk I, Weintraubv I . Long-term follow-up of distal intestinal obstruction syndrome in cystic fibrosis. World J Gastroenterol. 2015; 21(1):318-25. PMC: 4284351. DOI: 10.3748/wjg.v21.i1.318. View

Nasr S, Hurwitz M, Brown R, Elghoroury M, Rosen D . Treatment of anorexia and weight loss with megestrol acetate in patients with cystic fibrosis. Pediatr Pulmonol. 1999; 28(5):380-2. DOI: 10.1002/(sici)1099-0496(199911)28:5<380::aid-ppul11>3.0.co;2-a. View

10.

Steinkamp G, Wiedemann B . Relationship between nutritional status and lung function in cystic fibrosis: cross sectional and longitudinal analyses from the German CF quality assurance (CFQA) project. Thorax. 2002; 57(7):596-601. PMC: 1746376. DOI: 10.1136/thorax.57.7.596. View

11.

Staufer K . Current Treatment Options for Cystic Fibrosis-Related Liver Disease. Int J Mol Sci. 2020; 21(22). PMC: 7696864. DOI: 10.3390/ijms21228586. View

12.

Beswick D, Humphries S, Balkissoon C, Strand M, Vladar E, Lynch D . Impact of Cystic Fibrosis Transmembrane Conductance Regulator Therapy on Chronic Rhinosinusitis and Health Status: Deep Learning CT Analysis and Patient-reported Outcomes. Ann Am Thorac Soc. 2021; 19(1):12-19. PMC: 8787790. DOI: 10.1513/AnnalsATS.202101-057OC. View

13.

Parrish C . Nutrition concerns for the patient with gastroparesis. Curr Gastroenterol Rep. 2007; 9(4):295-302. DOI: 10.1007/s11894-007-0033-0. View

14.

Munck A, Alberti C, Colombo C, Kashirskaya N, Ellemunter H, Fotoulaki M . International prospective study of distal intestinal obstruction syndrome in cystic fibrosis: Associated factors and outcome. J Cyst Fibros. 2016; 15(4):531-9. DOI: 10.1016/j.jcf.2016.02.002. View

15.

Feranchak A, Sontag M, Wagener J, Hammond K, Accurso F, Sokol R . Prospective, long-term study of fat-soluble vitamin status in children with cystic fibrosis identified by newborn screen. J Pediatr. 1999; 135(5):601-10. DOI: 10.1016/s0022-3476(99)70059-4. View

16.

Lanng S, Hansen A, Thorsteinsson B, Nerup J, Koch C . Glucose tolerance in patients with cystic fibrosis: five year prospective study. BMJ. 1995; 311(7006):655-9. PMC: 2551427. DOI: 10.1136/bmj.311.7006.655. View

17.

Lisowska A, Pogorzelski A, Oracz G, Siuda K, Skorupa W, Rachel M . Oral antibiotic therapy improves fat absorption in cystic fibrosis patients with small intestine bacterial overgrowth. J Cyst Fibros. 2011; 10(6):418-21. DOI: 10.1016/j.jcf.2011.06.008. View

18.

Borowitz D, Baker R, Stallings V . Consensus report on nutrition for pediatric patients with cystic fibrosis. J Pediatr Gastroenterol Nutr. 2002; 35(3):246-59. DOI: 10.1097/00005176-200209000-00004. View

19.

Dos Santos A, de Melo Santos H, Nogueira M, Tavora H, de Lourdes Jaborandy Paim da Cunha M, Seixas R . Cystic Fibrosis: Clinical Phenotypes in Children and Adolescents. Pediatr Gastroenterol Hepatol Nutr. 2018; 21(4):306-314. PMC: 6182489. DOI: 10.5223/pghn.2018.21.4.306. View

20.

McDonald C, Alvarez J, Bailey J, Bowser E, Farnham K, Mangus M . Academy of Nutrition and Dietetics: 2020 Cystic Fibrosis Evidence Analysis Center Evidence-Based Nutrition Practice Guideline. J Acad Nutr Diet. 2020; 121(8):1591-1636.e3. PMC: 8542104. DOI: 10.1016/j.jand.2020.03.015. View